A study published this week in the journal Nature Nanotechnology find, a molecule that is the main ingredient in green tea can be used as a carrier or carriers of anticancer protein, - forming a stable and effective of therapeutic nanocomplexes.
These findings by researchers could help build a better health care system. To come to this conclusion, Joo Eun Chung and colleagues used the molecule (-)-epigallocatechin-3-O-gallate (EGCG), which is found in high abundance in green tea, to create Herceptin or an anticancer protein carrier.
Excess EGCG compared to other carrier is to have anticancer effects as well. The researchers then injected nanocomplexes EGCG-Herceptin in mice. They then found that certain tumors in mice reduced growth in the longer term. The researchers say, some cancer treatment depends on the drugs consisting of drug therapy and a carrier that deliver drugs to the tumor site.
When designing a drug carrier, several factors must be considered, for example, have to attack the tumor. Then, the ratio of the drug carrier, because the use of high amounts can cause toxicity if the body is not able metabolizes it.
In addition, the drug could turn too complex becomes ineffective, if the body against (the drugs) and remove it too quickly, such as reported by Medical News Today. *** [EKA | FROM VARIOUS SOURCES | MEDICAL NEWS TODAY]
Note: This blog can be accessed via your smart phone.
